Progress in Recombinant DNA Technology to Provide Boost to Market

Over the past couple of decades, investments toward the development of advanced enzyme engineering technologies have witnessed exponential growth due to the widening application of biocatalysts across the medical sector. At present, scientists and researchers are focusing on addressing the shortcoming of conventional medical enzyme technologies, which is projected to redefine the future of the medical enzyme technology market during the forecast period. Several attempts are being made to enhance thermo-stability and other properties of medical-grade enzymes, which are expected to improve the overall prospects of the global medical enzyme technology market during the assessment period.

Strides taken by the recombinant DNA technology has played a key role in opening up new avenues for enzyme engineering due to which, diverse groups of effective enzymes are increasingly being developed. These enzymes are increasingly being used in various medical fields, including structural biology, diagnostics, biochemistry, biocatalysts, and therapeutics, among others. The past few years have witnessed consistent development across the enzyme engineering sector and the trend is expected to gain considerable momentum in the forthcoming decade. At the back of these factors, along with an array of underlying drivers, the global medical enzyme technology market is expected to attain a market value of ~US$ 6.8 Bn by the end of 2030.

medical enzymes technology market infographic

Request a sample to get extensive insights into the Medical Enzyme Technology Market

Growing Importance in Clinical Diagnosis and Treatment to Aid Market Growth

At present, medical enzyme technology is aimed at improving the efficacy of enzymatic diagnosis. The Medical enzyme technology is increasingly being deployed to enhance enzymatic diagnostic techniques across the world– a factor that is expected to provide an impetus for the growth of the global medical enzyme technology market. In addition, the growing adoption of enzymes for disease prevention and treatment is a leading factor that is projected to accelerate innovations across the medical enzyme technology market. Moreover, due to research and development, an array of enzymes are being used to address a host of medical problems. For instance, trypsin is increasingly being used to fasten wound healing dissolving blood clots, etc. to eliminate the necrotic tissue and inhibit the growth of contaminating microorganisms.

Furthermore, the medical enzyme technology is extensively being used in several applications, including disease treatment such as cancer, metabolic disorders, etc. For instance, L-asparaginase is being used for cancer treatment, as it restricts the growth of cancer cells. Multi-enzyme tablets such as protease have also gained considerable popularity as an anti-inflammatory due to which, the demand for the same is likely to witness consistent growth. While advancements in the medical enzyme technology market continue to fuel the development of new diagnostic reagents in medical treatment, enzymes are increasingly being used in medicine production. Over the past few years, studies have revealed that enzymes play a pivotal role in the field of clinical diagnosis and treatment. Advancements in bioengineering coupled with soaring interest in the medical enzyme technology are some of the top factors that are likely to accelerate the growth of the global medical enzyme technology market during the assessment period.

Research and Development Activities Likely to Boost Adoption of New Technologies

At present, medical enzyme technologies are predominantly emphasizing on improving the quality and efficacy of drugs that are used to treat a range of medical conditions, including diabetes, obesity, and cancer. Research and development activities are expected to set the tone for the future of the global medical enzyme technology market in the upcoming years. Over the past few years, researchers are increasingly focusing on enhancing the efficacy of drugs used to address obesity, cancer, and other treatments by deploring the medical enzyme technology.

In addition, a recent discovery of a new enzyme is expected to improve the quality of the drugs used to treat these conditions. In the past few years, an array of drugs that primarily focus on HDAC enzymes have gained considerable attention from drug developers and other stakeholders operating in the global medical enzyme technology market due to their contribution in building resistance toward cancer treatments.

medical enzymes technology market segmentation

To understand how our report can bring difference to your business strategy, Ask for a brochure

Researchers Focus on Exploring Potential Benefits of Human Enzymes to Curb COVID-19

The ongoing COVID-19 pandemic has led to considerable developments across the healthcare sector. While several core industrial sectors are suffering major losses during the pandemic due to the lockdown, the healthcare sector is increasingly being pressurized to discover a potential vaccine, drugs, or medication to curb the novel COVID-19 disease. At present, considerable research is being carried out to explore the potential of human enzymes to exacerbate COVID-19. Drug developers, along with the research fraternity are exploring different strategies for COVID-19 management and treatment by investigating the benefits of human enzymes for the same. While the market growth is expected to remain sluggish in the first half of 2020, the potential or new discoveries that are likely to offer promising results in the fight against COVID-19 could provide a boost to the prospects of medical enzyme technology market.

Expanding operations in future? To get the perfect launch ask for a custom report 

Analysts’ Viewpoint

The global medical enzyme technology market is expected to grow at an impressive CAGR during the assessment period. Advancements in enzyme engineering coupled with rapid development in the DNA technology will play a key role in the overall development of the global enzyme technology market during the assessment period. In addition, research and development activities will play an important role in the discovery of new medical enzyme technologies that are likely to improve the quality and efficacy of drugs used to treat cancer, obesity, and diabetes. Market players should focus on research and collaborate with research & scientific institutes to establish a solid foothold in the medical enzyme technology market landscape during the forecast period.

Medical Enzyme Technology Market: Overview

  • The global medical enzyme technology market was valued at US$ 3.7 Bn in 2019. It is projected to expand at a considerable CAGR from 2020 to 2030. Enzymes can be defined as the complex proteins that catalyze a specific reaction or a chemical change in all parts of the body. The medical applications of enzymes have been in development rampantly owing to their innate availability and their magnitude of rewards offered in disease treatment and as diagnostic tools.
  • Rise in demand for medical enzyme technology can be attributed to the increasing prevalence of chronic diseases, including cancer and cardiovascular diseases, growing usage of enzyme therapies, increasing investment in research and development, strategic partnerships among market players, and rising use of enzymes for various therapeutic and diagnostic purposes, among others

Medical Enzyme Technology Market: Segmentation

  • The global medical enzyme technology market has been segmented based on enzyme type, application, and region
  • In terms of enzyme type, the global medical enzyme technology market has been categorized into digestive enzymes, thrombolytic enzymes, hydrolases, and others. The digestive enzymes segment has been further segmented into L-asparginase, lactase, and others. The thrombolytic enzymes segment has been further divided into streptokinase, urokinase, and others. The hydrolases segment includes hyaluronidase, lysozyme, and others as sub-segments. The medical enzyme technology market was dominated by the hydrolases segment in 2019.
  • Based on application, the global medical enzyme technology market has been classified into disease treatment, diagnostic tools, biomedical research, and others. The disease treatment segment is further divided into cancer (chemotherapy), metabolic disorders, and others. The diagnostic tools segment is further segmented into renal diseases, cancer, and others. The disease treatment segment dominated the medical enzyme technology market in 2019.

Medical Enzyme Technology Market: Regional Segmentation

  • In terms of region, the global medical enzyme technology market has been classified into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America dominated the global medical enzyme technology market in 2019, and the trend is expected to continue during the forecast period. Expansion of the medical enzyme technology market in the region can be attributed to increasing prevalence of chronic diseases, growing demand for enzyme replacement therapies, increasing investment in research and development, and strong presence of market players, among others.
  • Europe was the second highest revenue-generating region in the medical enzyme technology market in 2019. Growth of the medical enzyme technology market in the region can be attributed to the presence of leading market players, rise in adoption of technological advancements in medical enzyme technology, increase in awareness among the people about enzyme therapies, and strategic acquisitions & partnerships among leading players.
  • The medical enzyme technology market in Asia Pacific is anticipated to expand at a high CAGR from 2020 to 2030. Expansion of the medical enzyme technology market in the region can be attributed to the increasing awareness among people, significant advancements in biotechnology, increase in adoption of technological advancements, and rise in pharmaceutical production.

Medical Enzyme Technology Market: Major Players

  • Key players operating in the global medical enzyme technology market include 
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Genzyme Corporation (Sanofi)
    • Promega Corporation
    • Asahi Kasei Corporation
    • Takeda Pharmaceutical Company Limited
    • Cytiva (Danaher)
    • Agilent Technologies, Inc.
    • Sun Pharmaceutical Industries Ltd.
    • Amano Enzyme Inc.
    • Novozymes A/S
  • The market for medical enzyme technology is dominated by few players. Thermo Fisher Scientific, Inc. is one of the leading players in the medical enzyme technology market. The company is engaged in offering a range of enzymes through its Affymetrix business.
  • Companies in the medical enzyme technology market have been adopting inorganic growth strategies to consolidate their position in the global medical enzyme technology market. For instance, In October 2018, Thermo Fisher Scientific, Inc. acquired Advanced Bioprocessing business. This acquisition is likely to benefit the Life Sciences Solutions segment of the company.

Medical Enzyme Technology Market – Scope of the Report

TMR’s report on the global medical enzyme technology market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the global market during the forecast period from 2020 to 2030. The report provides the overall revenue of the global medical enzyme technology market from 2018 to 2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global medical enzyme technology market for the forecast period.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with market leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global medical enzyme technology market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts also employed a combination of top-down and bottom-up approaches to study various phenomena in the global medical enzyme technology market.

The report includes an elaborate executive summary, along with a snapshot of the growth pattern of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on the changing competition dynamics in the global medical enzyme technology market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global medical enzyme technology market. The next section of the report highlights the USPs, which include key industry events (mergers, acquisitions, partnerships, collaborations, etc.), technological advancements, major research institutes involved, disease prevalence & incidence rate globally with key countries, and COVID-19 pandemic impact on the industry (value chain and short/mid/long term impact), in the global medical enzyme technology market.

The report delves into the competition landscape of the global medical enzyme technology market. Key players operating in the global medical enzyme technology market have been identified and each one of these has been profiled for its distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global medical enzyme technology market report.

Key Questions Answered in Medical Enzyme Technology Market Report

  • What will be the sales revenue generated by medical enzyme technology across all regions during the forecast period?
  • What are the key trends in the global medical enzyme technology market?
  • What are major drivers, restraints, and opportunities in the global medical enzyme technology market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which application segment will generate the maximum revenue by 2030 and which service type segment will expand at the fastest CAGR during the forecast period?

Medical Enzyme Technology Market – Research Objectives and Research Approach

The comprehensive report on the global medical enzyme technology market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and healthcare compliances laid down by accredited agencies in the purview of research in the global medical enzyme technology market. It is followed by market introduction, market dynamics, and an overview of the global medical enzyme technology market, which includes TMR’s analysis of market drivers, restraints, and trends affecting the market. Furthermore, Y-o-Y growth analysis with elaborate insights has been provided to understand the Y-o-Y growth trends of the global market. The next section of the global medical enzyme technology market report highlights the USPs, which include key industry events (mergers, acquisitions, partnerships, collaborations, etc.), technological advancements, major research institutes involved, disease prevalence & incidence rate globally with key countries, and COVID-19 pandemic impact on industry (value chain and short/mid/long term impact), in the global medical enzyme technology market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

Revenue generated by key players in the global medical enzyme technology market has been mapped to ascertain the size of the market in terms of value. The forecast presented here assesses the total revenue generated in the global medical enzyme technology market. In order to provide an accurate forecast, we initiated by sizing up the current medical enzyme technology market with the help of the parent market.

The report analyzes the global medical enzyme technology market in terms of enzyme type, application, and region. Key segments under each criteria have been studied at length and the market share of each of these by the end of 2030 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the global medical enzyme technology market.

Medical Enzyme Technology Market – Segmentation

Enzyme Type

  • Digestive Enzymes
    • L-asparginase
    • Lactase
    • Others
  • Thrombolytic Enzymes
    • Streptokinase
    • Urokinase
    • Others
  • Hydrolases
    • Hyaluronidase
    • Lysozyme
    • Others
  • Others

Application

  • Disease Treatment
    • Cancer (Chemotherapy)
    • Metabolic Disorders
    • Others
  • Diagnostic Tools
    • Renal Disease
    • Cancer
    • Others
  • Biomedical Research
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Medical Enzymes Technology

Buy Now